2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Carcinoma, Hepatocellular
23
Liver Neoplasms
4
Recurrence
2
Carcinoma, Non-Small-Cell Lung
2
Uveal Melanoma
1
Sarcoma
1
Recurrence Hepatocellular Carcinoma
1
Pleural Neoplasms
1
Pancreatic Adenocarcinoma
1
Neuroendocrine Tumors
1
Neoplastic Cells, Circulating
1
Neoplasm Recurrence, Local
1
Mediastinal Neoplasms
1
Malignant Neoplasm in the Head and Neck
1
Lung Neoplasms
1
Lung Metastases
1
Liver Cirrhosis
1
Hypoxia
1
HCC
1
Colorectal Cancer Metastatic
1
Colonic Neoplasms
1
Interventions
Sorafenib
2
nimotuzumab
1
lenvatinib
1
atezolizumab
1
Tirapazamine
1
Stents
1
Radiotherapy
1
Radiosurgery
1
Radiofrequency Ablation
1
Immune Checkpoint Inhibitors
1
Hematologic Tests
1
Ethiodized Oil
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
HCC
×
Ethiodized Oil
×
Clear all
NCT03108248
2017-04-11
ISP-TACE Versus TACE for HCC With PVTT
Zhongda Hospital
Completed
126 enrolled